文献速递鼻科咽喉与嗓音

选择性PAR2抑制减轻屋尘螨诱导的人气道上皮与小鼠过敏性鼻炎和哮喘模型中的Th1/Th2反应

Selective PAR2 Inhibition Attenuates HDM-Induced Th1/Th2 Responses in Human Epithelial and Murine Models of Allergic Rhinitis and Asthma.
PubMed 文献 · Int Forum Allergy Rhinol · 2025-07-11

本研究探讨选择性PAR2抑制对人鼻上皮细胞及屋尘螨诱导的小鼠过敏性鼻炎和哮喘模型的影响。结果显示PAR2抑制可抑制Th2(IL-33、TSLP)和Th1(TNF-α、IL-6)炎性细胞因子,并抑制钙动员及ERK/NF-κB信号通路;在PAR2野生型小鼠中,PAR2抑制剂减轻屋尘螨特异性IgE、气道高反应性和鼻及支气管组织的过敏性炎症,与PAR2敲除小鼠的抗炎表现一致。作者认为PAR2可能是过敏性鼻炎和哮喘的潜在靶点。

要点

  • PAR2抑制在人气道上皮细胞中抑制Th2(IL-33、TSLP)与Th1(TNF-α、IL-6)细胞因子。
  • PAR2抑制剂降低PAR2野生型小鼠屋尘螨特异性IgE、气道高反应性及鼻和支气管过敏性炎症。
  • PAR2抑制的抗炎表现与PAR2敲除小鼠一致,作者认为PAR2可能是潜在靶点。

核心结论

  • 选择性PAR2抑制通过调节Th1和Th2通路,有效减轻人气道上皮和小鼠模型中屋尘螨诱导的过敏性炎症。
  • 作者认为PAR2可能是过敏性鼻炎和哮喘的潜在靶点。

研究设计与样本

  • 研究使用原代人鼻上皮细胞以及屋尘螨诱导的PAR2野生型(PAR2-wt)和PAR2敲除(PAR2-ko)小鼠模型。
  • 分析包括炎症信号通路、细胞因子谱、气道反应、组织病理学和转录组学。

主要发现

  • 在人鼻上皮细胞中,PAR2抑制抑制Th2细胞因子(IL-33、TSLP)和Th1细胞因子(TNF-α、IL-6),同时抑制钙动员及ERK/NF-κB信号级联。
  • 在PAR2野生型小鼠中,PAR2抑制剂治疗降低屋尘螨特异性IgE、气道高反应性以及鼻和支气管组织的过敏性炎症,与PAR2敲除小鼠的抗炎表现一致。
  • 批量RNA测序证实炎症基因表达被全面抑制。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Allergic rhinitis (AR) and asthma are involved in complex interactions between Th1 and Th2 inflammatory pathways. House dust mite (HDM) activates protease-activated receptor 2 (PAR2) to trigger inflammatory responses, but current treatments often provide inadequate control. OBJECTIVE: This study aimed to investigate the effects of selective PAR2 inhibition on Th1 and Th2 responses in human nasal epithelial (HNE) cells and murine models of AR and asthma. METHODS: We examined the effects of selective PAR2 inhibition using primary HNE cells and HDM-induced mouse models (PAR2-wild-type [PAR2-wt] and knockout [PAR2-ko]). Analyses included inflammatory signaling pathways, cytokine profiles, airway responses, histopathology, and transcriptomics. RESULTS: In HNE cells, PAR2 inhibition suppressed Th2 (interleukin [IL]-33, TSLP) and Th1 (TNF-α, IL-6) inflammatory cytokines while inhibiting calcium mobilization and ERK/NF-κB signaling cascades. In PAR2-wt mice, treatment with the PAR2 inhibitor reduced HDM-specific Immunoglobulin E (IgE), airway hyperresponsiveness, and allergic inflammation in both nasal and bronchial tissues, matching the anti-inflammatory profile of PAR2-ko mice. Bulk RNA sequencing confirmed comprehensive suppression of inflammatory gene expression. CONCLUSIONS: Selective PAR2 inhibition effectively attenuates HDM-induced allergic inflammation by modulation of Th1 and Th2 pathways in human airway epithelium and murine models. We suggest that PAR2 can be a possible target for AR and asthma.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Kang M, Seo Y, Seo JH, et al. Selective PAR2 Inhibition Attenuates HDM-Induced Th1/Th2 Responses in Human Epithelial and Murine Models of Allergic Rhinitis and Asthma. Int Forum Allergy Rhinol. 2025. PMID: 40644479. doi:10.1002/alr.23623

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。